Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03652272 · ClinicalTrials.gov registry record · NA
Development and Evaluation of an Electronic Health Record-based Medication Complete Communication (EMC2) Strategy
A NA study, sponsored by Northwestern University.
- Completed
- Registry status
- NA
- Development phase
- 301
- Enrollment target
NCT03652272 is a NA study that has completed, run by Northwestern University. The registered enrollment target is 301 participants.
The verdict
NCT03652272, a NA study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 301 participants
- Enrollment target
Study Summary
There is a well-documented need for effective interventions that can help patients understand and safely adhere to prescribed medications, particularly those with greater potential for harm if not taken correctly. The investigators will leverage health and consumer technologies with their EHR-based Medication Complete Communication (EMC2) Strategy to: 1) inform patients about medication risks and safe use, 2) promote provider education and counseling about prescribed drugs and 3) monitor patient adherence outside of visits. The EMC2 Strategy could be feasible, sustainable, and readily available to ambulatory care practices.
Interventions
- BEHAVIORAL EMC2
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 301 participants |
| Start Date | 2019-02-08 |
| Est. Completion | 2021-09-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03652272
The ClinicalTrials.gov registry entry for NCT03652272 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 301 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which EMC2 is the first listed.
NCT03652272 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03652272 about?
NCT03652272 is a clinical study titled "Development and Evaluation of an Electronic Health Record-based Medication Complete Communication (EMC2) Strategy". There is a well-documented need for effective interventions that can help patients understand and safely adhere to prescribed medications, particularly those with greater potential for harm if not taken correctly. The investigators will leverage health and consumer technologies with their EHR-based ...
What is the current status of trial NCT03652272?
This trial is currently completed. It is a NA study. The enrollment target is 301 participants. The study started on 2019-02-08. Estimated completion is 2021-09-27.
What interventions are being tested in trial NCT03652272?
The interventions under investigation include: EMC2 (BEHAVIORAL).
Who is sponsoring clinical trial NCT03652272?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.